[go: up one dir, main page]

WO2000028032A3 - Human cell surface receptor proteins - Google Patents

Human cell surface receptor proteins Download PDF

Info

Publication number
WO2000028032A3
WO2000028032A3 PCT/US1999/026742 US9926742W WO0028032A3 WO 2000028032 A3 WO2000028032 A3 WO 2000028032A3 US 9926742 W US9926742 W US 9926742W WO 0028032 A3 WO0028032 A3 WO 0028032A3
Authority
WO
WIPO (PCT)
Prior art keywords
cell surface
human cell
surface receptor
receptor proteins
hcsrp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1999/026742
Other languages
French (fr)
Other versions
WO2000028032A2 (en
Inventor
Y Tom Tang
Neil C Corley
Karl J Guegler
Henry Yue
Mariah R Baughn
Preeti Lal
Jennifer L Hillman
Olga Bandman
Yalda Azimzai
Janice Au-Young
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Pharmaceuticals Inc filed Critical Incyte Pharmaceuticals Inc
Priority to CA002349815A priority Critical patent/CA2349815A1/en
Priority to JP2000581199A priority patent/JP2005500801A/en
Priority to EP99958913A priority patent/EP1129189A2/en
Priority to AU16185/00A priority patent/AU1618500A/en
Publication of WO2000028032A2 publication Critical patent/WO2000028032A2/en
Publication of WO2000028032A3 publication Critical patent/WO2000028032A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The invention provides human cell surface receptor proteins (HCSRP) and polynucleotides which identify and encode HCSRP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expression of HCSRP.
PCT/US1999/026742 1998-11-12 1999-11-12 Human cell surface receptor proteins Ceased WO2000028032A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA002349815A CA2349815A1 (en) 1998-11-12 1999-11-12 Human cell surface receptor proteins
JP2000581199A JP2005500801A (en) 1998-11-12 1999-11-12 Human cell surface receptor protein
EP99958913A EP1129189A2 (en) 1998-11-12 1999-11-12 Human cell surface receptor proteins
AU16185/00A AU1618500A (en) 1998-11-12 1999-11-12 Human cell surface receptor proteins

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US19128098A 1998-11-12 1998-11-12
US09/191,280 1998-11-12
US20664798A 1998-12-07 1998-12-07
US09/206,647 1998-12-07
US12340499P 1999-03-08 1999-03-08
US60/123,404 1999-03-08

Publications (2)

Publication Number Publication Date
WO2000028032A2 WO2000028032A2 (en) 2000-05-18
WO2000028032A3 true WO2000028032A3 (en) 2000-11-16

Family

ID=27382949

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/026742 Ceased WO2000028032A2 (en) 1998-11-12 1999-11-12 Human cell surface receptor proteins

Country Status (3)

Country Link
AU (1) AU1618500A (en)
CA (1) CA2349815A1 (en)
WO (1) WO2000028032A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7129338B1 (en) 1999-07-08 2006-10-31 Research Association For Biotechnology Secretory protein or membrane protein

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1067182A3 (en) * 1999-07-08 2001-11-21 Helix Research Institute Secretory protein or membrane protein
WO2001094385A2 (en) * 2000-06-05 2001-12-13 Bayer Aktiengesellschaft Human hm74-like g protein coupled receptor
DE60136212D1 (en) * 2000-08-15 2008-11-27 Univ Johns Hopkins Med DIAGNOSIS AND TREATMENT OF TUMOR SUPPRESSOR ASSOCIATED DISEASES
EP1201681A1 (en) 2000-10-30 2002-05-02 Millennium Pharmaceuticals, Inc. "Fail" molecules and uses thereof
CN1547617A (en) * 2001-06-25 2004-11-17 2 Medicine innovation for oncology
US7527935B2 (en) 2002-03-19 2009-05-05 Mitsubishi Tanabe Pharma Corporation G-protein coupled receptor having eicosanoid as ligand and gene thereof
AU2003220913A1 (en) * 2002-03-19 2003-09-29 Tanabe Seiyaku Co., Ltd. Novel g protein-coupled recepotrs and genes thereof
US7183062B2 (en) * 2003-12-30 2007-02-27 Aventis Pharmaceuticals Inc. Prostaglandin receptor protein and methods of use thereof
WO2005082003A2 (en) * 2004-02-24 2005-09-09 Alexion Pharmaceuticals, Inc. Peptides and uses thereof
ES2625259T3 (en) 2006-08-29 2017-07-19 Oxford Biotherapeutics Ltd Identification of protein associated with hepatocellular carcinoma, glioblastoma and lung cancer
PL2403878T3 (en) 2009-03-05 2017-12-29 E. R. Squibb & Sons, L.L.C. Fully human antibodies specific to cadm1

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992014750A1 (en) * 1991-02-19 1992-09-03 The Regents Of The University Of California Recombinant thrombin receptor and related pharmaceuticals
WO1994005695A1 (en) * 1992-09-10 1994-03-17 New York University Polypeptides of g-coupled receptor proteins, and compositions and methods thereof
WO1998018456A1 (en) * 1996-10-30 1998-05-07 The Regents Of The University Of California Protease-activated receptor 3 and uses thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992014750A1 (en) * 1991-02-19 1992-09-03 The Regents Of The University Of California Recombinant thrombin receptor and related pharmaceuticals
WO1994005695A1 (en) * 1992-09-10 1994-03-17 New York University Polypeptides of g-coupled receptor proteins, and compositions and methods thereof
WO1998018456A1 (en) * 1996-10-30 1998-05-07 The Regents Of The University Of California Protease-activated receptor 3 and uses thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL NUCLEOTIDE SEQU 1 January 1900 (1900-01-01), XP002132666, Database accession no. AC008515 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7129338B1 (en) 1999-07-08 2006-10-31 Research Association For Biotechnology Secretory protein or membrane protein

Also Published As

Publication number Publication date
WO2000028032A2 (en) 2000-05-18
CA2349815A1 (en) 2000-05-18
AU1618500A (en) 2000-05-29

Similar Documents

Publication Publication Date Title
WO1999061471A3 (en) Human transmembrane proteins
WO2001012662A3 (en) Membrane associated proteins
WO2000015793A3 (en) Human gpcr proteins
WO2000018922A8 (en) Human carbohydrate-associated proteins
WO2000034477A3 (en) Neuron-associated proteins
WO1999058692A3 (en) Human apoptosis associated proteins
WO2000029583A3 (en) Immunoglobulin superfamily proteins
WO2000012711A3 (en) Human membrane channel proteins
WO2000009709A3 (en) Proteases and associated proteins
WO2000017355A3 (en) Human cytoskeleton associated proteins
WO2001007612A3 (en) Receptors and associated proteins
WO2000014251A3 (en) Human transferase proteins
WO2000052151A3 (en) Human secretory proteins
WO2000028032A3 (en) Human cell surface receptor proteins
WO2000005374A3 (en) Molecules associated with cell proliferation
WO2000000594A3 (en) Human transferases
WO1999058558A3 (en) Cell signaling proteins
WO2000020590A3 (en) G-protein coupled receptor proteins
WO1999061614A3 (en) Human socs proteins
WO2000031263A3 (en) Gtpase associated proteins
WO2000015770A3 (en) Human serine/threonine protein kinases
WO2000028029A3 (en) Cell surface glycoproteins
WO1999057270A3 (en) Human receptor molecules
WO2000028045A3 (en) Human hydrolase proteins
WO2000065054A3 (en) Human membrane-associated proteins

Legal Events

Date Code Title Description
ENP Entry into the national phase

Ref country code: AU

Ref document number: 2000 16185

Kind code of ref document: A

Format of ref document f/p: F

AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US US US US US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US US US US US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 09831458

Country of ref document: US

ENP Entry into the national phase

Ref document number: 2349815

Country of ref document: CA

Ref country code: CA

Ref document number: 2349815

Kind code of ref document: A

Format of ref document f/p: F

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2000 581199

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1999958913

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1999958913

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 1999958913

Country of ref document: EP